Paperpal Prime Logo

Breast Cancer: Targets and Therapy : Impact Factor & More

eISSN: 1179-1314pISSN: 1179-1314
JournalOpen Access

Key Metrics

CiteScore
5.9
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.51
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Breast Cancer: Targets and Therapy

Breast Cancer: Targets and Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Breast Cancer: Targets and Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Breast Cancer: Targets and Therapy

Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis [Retraction]
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
Pan-Cancer Analysis of a Depression-Related Gene Signature Identifies an Immunosuppressive Tumor Microenvironment and Links to Immunotherapy Response in Breast Cancer
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
Willingness to Undergo Corrective Surgery After Breast-Conserving Surgery in Chinese Patients with Breast Deformities: A Single-Center Study
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
Hemodynamic Inflow-Outflow Profiling as an Integrated DCE-MRI Biomarker for Diagnosis and Risk Stratification in Breast Cancer: A Multicenter Retrospective Study
  • 9 Jun 2026
  • Breast Cancer : Targets and Therapy
Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
  • 3 Jun 2026
  • Breast Cancer : Targets and Therapy
Rab1A-Mediated Exosomal Sorting of miR-200c Enhances Breast Cancer Lung Metastasis [Retraction]
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
Pan-Cancer Analysis of a Depression-Related Gene Signature Identifies an Immunosuppressive Tumor Microenvironment and Links to Immunotherapy Response in Breast Cancer
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
HER2 Heterogeneity in Breast Cancer: Biological Basis, Clinical Implications, and Therapeutic Strategies
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
Willingness to Undergo Corrective Surgery After Breast-Conserving Surgery in Chinese Patients with Breast Deformities: A Single-Center Study
  • 12 Jun 2026
  • Breast Cancer : Targets and Therapy
Hemodynamic Inflow-Outflow Profiling as an Integrated DCE-MRI Biomarker for Diagnosis and Risk Stratification in Breast Cancer: A Multicenter Retrospective Study
  • 9 Jun 2026
  • Breast Cancer : Targets and Therapy
Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan
  • 3 Jun 2026
  • Breast Cancer : Targets and Therapy

FAQs on Breast Cancer: Targets and Therapy